Stock Scorecard
Stock Summary for Inmode Ltd (INMD) - $15.26 as of 10/8/2025 4:12:58 PM EST
Total Score
17 out of 30
Safety Score
43 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for INMD
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for INMD
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for INMD
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for INMD
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for INMD (43 out of 100)
| Stock Price Rating (Max of 10) | 6 |
| Historical Stock Price Rating (Max of 10) | 9 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 4 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 5 |
| Trading Volume (Max of 10) | 6 |
| Price to Earnings (Max of 10) | 9 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for INMD
Financial Details for INMD
Company Overview |
|
|---|---|
| Ticker | INMD |
| Company Name | Inmode Ltd |
| Country | USA |
| Description | InMode Ltd. (INMD) is a leading innovator in the field of minimally invasive aesthetic medicine, specializing in the design, development, and manufacturing of advanced medical devices that harness proprietary radiofrequency-assisted technologies. Headquartered in Yokneam, Israel, the company has established a strong presence in the global healthcare market by offering a diverse range of products for body contouring, skin rejuvenation, and surgical procedures, which enhance patient safety and outcomes. With a commitment to innovation and quality, InMode continues to capitalize on growing demand for effective non-invasive treatments, positioning itself as a vital player in the rapidly expanding aesthetic medical sector. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL DEVICES |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 10/29/2025 |
Stock Price History |
|
| Last Day Price | 15.26 |
| Price 4 Years Ago | 70.58 |
| Last Day Price Updated | 10/8/2025 4:12:58 PM EST |
| Last Day Volume | 653,478 |
| Average Daily Volume | 855,342 |
| 52-Week High | 19.85 |
| 52-Week Low | 13.14 |
| Last Price to 52 Week Low | 16.13% |
Valuation Measures |
|
| Trailing PE | 6.37 |
| Industry PE | 44.24 |
| Sector PE | 41.70 |
| 5-Year Average PE | 17.26 |
| Free Cash Flow Ratio | 4.46 |
| Industry Free Cash Flow Ratio | 37.96 |
| Sector Free Cash Flow Ratio | 30.25 |
| Current Ratio Most Recent Quarter | 9.60 |
| Total Cash Per Share | 3.42 |
| Book Value Per Share Most Recent Quarter | 9.94 |
| Price to Book Ratio | 1.56 |
| Industry Price to Book Ratio | 3.99 |
| Sector Price to Book Ratio | 32.02 |
| Price to Sales Ratio Twelve Trailing Months | 2.39 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.50 |
| Sector Price to Sales Ratio Twelve Trailing Months | 20.22 |
| Analyst Buy Ratings | 0 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 63,209,000 |
| Market Capitalization | 964,569,340 |
| Institutional Ownership | 59.21% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 50.00% |
| Annual Earnings Growth | -8.41% |
| Reported EPS 12 Trailing Months | 2.38 |
| Reported EPS Past Year | 0.78 |
| Reported EPS Prior Year | 1.78 |
| Net Income Twelve Trailing Months | 178,704,000 |
| Net Income Past Year | 181,275,000 |
| Net Income Prior Year | 197,919,000 |
| Quarterly Revenue Growth YOY | 10.60% |
| 5-Year Revenue Growth | 20.35% |
| Operating Margin Twelve Trailing Months | 23.90% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 216,237,000 |
| Total Cash Past Year | 155,329,000 |
| Total Cash Prior Year | 144,411,000 |
| Net Cash Position Most Recent Quarter | 216,237,000 |
| Net Cash Position Past Year | 155,329,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 703,813,000 |
| Total Stockholder Equity Prior Year | 787,372,000 |
| Total Stockholder Equity Most Recent Quarter | 628,437,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 104,171,439 |
| Free Cash Flow Per Share Twelve Trailing Months | 1.65 |
| Free Cash Flow Past Year | 131,995,000 |
| Free Cash Flow Prior Year | 176,121,000 |
Options |
|
| Put/Call Ratio | 0.49 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.15 |
| MACD Signal | 0.12 |
| 20-Day Bollinger Lower Band | 13.36 |
| 20-Day Bollinger Middle Band | 14.49 |
| 20-Day Bollinger Upper Band | 15.63 |
| Beta | 2.09 |
| RSI | 56.61 |
| 50-Day SMA | 16.15 |
| 150-Day SMA | 23.38 |
| 200-Day SMA | 26.58 |
System |
|
| Modified | 10/7/2025 2:09:47 AM EST |